Psyence Biomedical Ltd. NEW YORK, Dec. 27, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence Biomed” or the “Company”) today announced that it has closed its ...

NEW YORK, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence Biomed” or the “Company”) today announced that it has received notice from the Nasdaq Hearings ...

Get Psyence Biomedical alerts: Psyence Biomedical (NASDAQ:PBM – Get Free Report) last announced its quarterly earnings data on Thursday, January 23rd. The company reported $0.51 EPS for the quarter.

Psyence Biomedical (PBM) has entered into definitive agreements for the purchase and sale of an aggregate of 1,000,000 common shares series A common warrants to purchase up to 1,000,000 common ...

NEW YORK, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) ("Psyence Biomed” or the "Company") today announced that it has entered into definitive agreements for the purchase ...

Psyence Biomedical Ltd. has completed a private placement, raising approximately $2 million by selling 1,000,000 common shares along with series A and series B common warrants, with an exercise ...

Psyence Biomedical Ltd. announced that it has regained compliance with Nasdaq's continued listing requirements, as confirmed by the Nasdaq Hearings panel. Following a transfer to The Nasdaq ...

TORONTO, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Psyence Group Inc ("Psyence Group" or the "Company") (CSE: PSYG) hereby announces that it has entered into an addendum to the previously announced debt ...

Psyence Biomedical Ltd. (PBM) stock price is 1.64 and Psyence Biomedical Ltd. (PBM) 10-day simple moving average is 1.68. Psyence Biomedical Ltd. (PBM) stock price is 1.64 and Psyence Biomedical Ltd.